BioCorRx Inc. (BICX)

[BearsNBulls]

The meeting on September 19th is a meeting between the executives and the FDA counsel. The FDA counsel will look over paperwork, available data and information provided by BioCorRX about BICX101. Brady Granier, the CEO will try to bypass safety data due to Vivatrol data already having been done through trials.

The FDA counsel will review all documents, etc then give valuable recommendations to BioCorRX. After that meeting the FDA trial process will begin. There's a chance it may get fast tracked, accelerated, etc. We know we're going to be starting a trial after that meeting, we won't know until right after the meeting how long of a time frame until FDA total approval.

Most investors believe we will have BICX101 approved next year.

Check out BioCorRX twitter page, there's a tweet about PRE IND FDA meetings and how valuable and helpful they are to a company.